Market Research Report

Global Aromatase Inhibitors Market Report By Drug (Formestane, Fadrozole, Exemestane, Anastrozole, Letrozole, Others), By Mode Of Action (Selective Inhibitors, Non-Selective Inhibitors), By Route Of Administration (Oral, Parenteral), By End Users (Hospitals, Homecare, Specialty Clinics, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

ID:VMR11218291
May 2022
Report Formats: Electronic (PDF), MS EXCEL
The global demand for Aromatase Inhibitors Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.

Aromatase inhibitors are drugs that work by inhibiting the enzyme aromatase, which converts androgens into oestrogen. Aromatase inhibitor drugs treat breast cancer by reducing estrogen levels in blood circulation. Aromatase inhibitor drugs are also off-label to facilitate estrogen conversion when using external testosterone. Aromatase inhibitors are used for chemoprevention in high-risk women. Aromatase inhibitors are supportive and aim to reduce the severity of the symptoms. 

Market Dynamics 

The rise in prevalence of breast cancer globally boosts demand for the aromatase inhibitors market. Moreover, the growth and expansion of the healthcare industry, especially in the developing economies, would invite the use and application of new and advanced medical technologies, equipment, and drugs will directly increase the demand for aromatase inhibitors. Furthermore, an increase in the demand for effective therapies and a rising adoption rate for early diagnostic procedures will boost the inhibitor's market growth rate. However, the high costs associated with research and development capabilities will emerge as one of the most significant restraints for the aromatase inhibitors market.

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of aromatase inhibitors. The growth and trends of aromatase inhibitors industry provide a holistic approach to this study. 

Market Segmentation

This section of the aromatase inhibitors market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Drug
  • Formestane
  • Fadrozole
  • Exemestane
  • Anastrozole
  • Letrozole
  • Others

By Mode Of Action
  • Selective Inhibitors
  • Non-Selective Inhibitors

By Route Of Administration
  • Oral
  • Parenteral

By End Users
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Distribution Channel
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Aromatase Inhibitors market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Aromatase Inhibitors Market Share by Region (Representative Graph)

Global Aromatase Inhibitors Market Share
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the aromatase inhibitors market include Pfizer Inc, AstraZeneca, ANI Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Hikma Pharmaceuticals PLC, Teva Pharmaceutical Industries Ltd, Zydus Cadila, Cipla Inc., Amneal Pharmaceuticals LLC, Glenmark Pharmaceuticals Limited, Fresenius Kabi AG, Mayne Pharma Group Limited, Mylan N.V., Novartis AG., Vintage Labs, Dr. Reddy’s Laboratories Ltd, Jiangsu Hengrui Medicine Co., Ltd, Novo Nordisk A/S, Otsuka America Pharmaceutical, Inc., and WOCKHARDT. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . AROMATASE INHIBITORS – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 Market Attractiveness Analysis By Drug
           3.7.2 Market Attractiveness Analysis By Mode Of Action
           3.7.3 Market Attractiveness Analysis By Route Of Administration
           3.7.4 Market Attractiveness Analysis By End Users
           3.7.5 Market Attractiveness Analysis By Distribution Channel
           3.7.6 Market Attractiveness Analysis By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic 
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL AROMATASE INHIBITORS MARKET ANALYSIS BY DRUG
       6.1 Overview by Drug
       6.2 Historical and Forecast Data
       6.3 Analysis by Drug
       6.4 Formestane Historic and Forecast Sales by Regions
       6.5 Fadrozole Historic and Forecast Sales by Regions
       6.6 Exemestane Historic and Forecast Sales by Regions
       6.7 Anastrozole Historic and Forecast Sales by Regions
       6.8 Letrozole Historic and Forecast Sales by Regions
       6.9 Others Historic and Forecast Sales by Regions
 
7 . GLOBAL AROMATASE INHIBITORS MARKET ANALYSIS BY MODE OF ACTION
       7.1 Overview by Mode Of Action
       7.2 Historical and Forecast Data
       7.3 Analysis by Mode Of Action
       7.4 Selective Inhibitors Historic and Forecast Sales by Regions
       7.5 Non-Selective Inhibitors Historic and Forecast Sales by Regions
 
8 . GLOBAL AROMATASE INHIBITORS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
       8.1 Overview by Route Of Administration
       8.2 Historical and Forecast Data
       8.3 Analysis by Route Of Administration
       8.4 Oral Historic and Forecast Sales by Regions
       8.5 Parenteral Historic and Forecast Sales by Regions
 
9 . GLOBAL AROMATASE INHIBITORS MARKET ANALYSIS BY END USERS
       9.1 Overview by End Users
       9.2 Historical and Forecast Data
       9.3 Analysis by End Users
       9.4 Hospitals Historic and Forecast Sales by Regions
       9.5 Homecare Historic and Forecast Sales by Regions
       9.6 Specialty Clinics Historic and Forecast Sales by Regions
       9.7 Others Historic and Forecast Sales by Regions
 
10 . GLOBAL AROMATASE INHIBITORS MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       10.1 Overview by Distribution Channel
       10.2 Historical and Forecast Data
       10.3 Analysis by Distribution Channel
       10.4 Hospital Pharmacy Historic and Forecast Sales by Regions
       10.5 Online Pharmacy Historic and Forecast Sales by Regions
       10.6 Retail Pharmacy Historic and Forecast Sales by Regions
       10.7 Others Historic and Forecast Sales by Regions
 
11 . GLOBAL AROMATASE INHIBITORS MARKET ANALYSIS BY GEOGRAPHY
       11.1. Top  Company Share Analysis
       11.2. Introduction
       11.3. North America Sales Analysis
           11.3.1. Overview, Historic and Forecast Sales Analysis
           11.3.2. North America By Segment Sales Analysis
           11.3.3. North America By Country Sales Analysis
           11.3.4. United State Sales Analysis
           11.3.5. Canada Sales Analysis
           11.3.6. Mexico Sales Analysis
       11.4. Europe Sales Analysis
           11.4.1. Overview, Historic and Forecast Sales Analysis
           11.4.2. Europe by Segment Sales Analysis
           11.4.3. Europe by Country Sales Analysis
           11.4.4. United Kingdom Sales Analysis
           11.4.5. France Sales Analysis
           11.4.6. Germany Sales Analysis
           11.4.7. Italy Sales Analysis
           11.4.8. Russia Sales Analysis
           11.4.9. Rest Of Europe Sales Analysis
       11.5. Asia Pacific Sales Analysis
           11.5.1. Overview, Historic and Forecast Sales Analysis
           11.5.2. Asia Pacific by Segment Sales Analysis
           11.5.3. Asia Pacific by Country Sales Analysis
           11.5.4. China Sales Analysis
           11.5.5. India Sales Analysis
           11.5.6. Japan Sales Analysis
           11.5.7. South Korea Sales Analysis
           11.5.8. Australia Sales Analysis
           11.5.9. Rest Of Asia Pacific Sales Analysis
       11.6. Latin America Sales Analysis
           11.6.1. Overview, Historic and Forecast Sales Analysis
           11.6.2. Latin America by Segment Sales Analysis
           11.6.3. Latin America by Country Sales Analysis
           11.6.4. Brazil Sales Analysis
           11.6.5. Argentina Sales Analysis
           11.6.6. Peru Sales Analysis
           11.6.7. Chile Sales Analysis
           11.6.8. Rest of Latin America Sales Analysis
       11.7. Middle East & Africa Sales Analysis
           11.7.1. Overview, Historic and Forecast Sales Analysis
           11.7.2. Middle East & Africa by Segment Sales Analysis
           11.7.3. Middle East & Africa by Country Sales Analysis
           11.7.4. Saudi Arabia Sales Analysis
           11.7.5. UAE Sales Analysis
           11.7.6. Israel Sales Analysis
           11.7.7. South Africa Sales Analysis
           11.7.8. Rest Of Middle East And Africa Sales Analysis
 
12 . COMPETITIVE LANDSCAPE OF THE AROMATASE INHIBITORS COMPANIES
       12.1. Aromatase Inhibitors Market Competition
       12.2. Partnership/Collaboration/Agreement
       12.3. Merger And Acquisitions
       12.4. New Product Launch
       12.5. Other Developments
 
13 . COMPANY PROFILES OF AROMATASE INHIBITORS INDUSTRY
       13.1. Company Share Analysis
       13.2. Market Concentration Rate
       13.3. Pfizer Inc
           13.3.1. Company Overview
           13.3.2. Company Revenue
           13.3.3. Products
           13.3.4. Recent Developments
       13.4. AstraZeneca
           13.4.1. Company Overview
           13.4.2. Company Revenue
           13.4.3. Products
           13.4.4. Recent Developments
       13.5. ANI Pharmaceuticals Inc.
           13.5.1. Company Overview
           13.5.2. Company Revenue
           13.5.3. Products
           13.5.4. Recent Developments
       13.6. Bristol-Myers Squibb Company
           13.6.1. Company Overview
           13.6.2. Company Revenue
           13.6.3. Products
           13.6.4. Recent Developments
       13.7. Hikma Pharmaceuticals PLC
           13.7.1. Company Overview
           13.7.2. Company Revenue
           13.7.3. Products
           13.7.4. Recent Developments
       13.8. Teva Pharmaceutical Industries Ltd
           13.8.1. Company Overview
           13.8.2. Company Revenue
           13.8.3. Products
           13.8.4. Recent Developments
       13.9. Zydus Cadila
           13.9.1. Company Overview
           13.9.2. Company Revenue
           13.9.3. Products
           13.9.4. Recent Developments
       13.10. Cipla Inc.
           13.10.1. Company Overview
           13.10.2. Company Revenue
           13.10.3. Products
           13.10.4. Recent Developments
       13.11. Amneal Pharmaceuticals LLC
           13.11.1. Company Overview
           13.11.2. Company Revenue
           13.11.3. Products
           13.11.4. Recent Developments
       13.12. Glenmark Pharmaceuticals Limited
           13.12.1. Company Overview
           13.12.2. Company Revenue
           13.12.3. Products
           13.12.4. Recent Developments
       13.13. Fresenius Kabi AG
           13.13.1. Company Overview
           13.13.2. Company Revenue
           13.13.3. Products
           13.13.4. Recent Developments
       13.14. Mayne Pharma Group Limited
           13.14.1. Company Overview
           13.14.2. Company Revenue
           13.14.3. Products
           13.14.4. Recent Developments
       13.15. Mylan N.V.
           13.15.1. Company Overview
           13.15.2. Company Revenue
           13.15.3. Products
           13.15.4. Recent Developments
       13.16. Novartis AG.
           13.16.1. Company Overview
           13.16.2. Company Revenue
           13.16.3. Products
           13.16.4. Recent Developments
       13.17. Vintage Labs
           13.17.1. Company Overview
           13.17.2. Company Revenue
           13.17.3. Products
           13.17.4. Recent Developments
       13.18. Dr. Reddy’s Laboratories Ltd
           13.18.1. Company Overview
           13.18.2. Company Revenue
           13.18.3. Products
           13.18.4. Recent Developments
       13.19. Jiangsu Hengrui Medicine Co. Ltd
           13.19.1. Company Overview
           13.19.2. Company Revenue
           13.19.3. Products
           13.19.4. Recent Developments
       13.20. Novo Nordisk A/S
           13.20.1. Company Overview
           13.20.2. Company Revenue
           13.20.3. Products
           13.20.4. Recent Developments
       13.21. Otsuka America Pharmaceutical Inc.
           13.21.1. Company Overview
           13.21.2. Company Revenue
           13.21.3. Products
           13.21.4. Recent Developments
       13.22. WOCKHARDT
           13.22.1. Company Overview
           13.22.2. Company Revenue
           13.22.3. Products
           13.22.4. Recent Developments     
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Drug (USD MN)
  •  Formestane Market Sales by Geography (USD MN)
  •  Fadrozole Market Sales by Geography (USD MN)
  •  Exemestane Market Sales by Geography (USD MN)
  •  Anastrozole Market Sales by Geography (USD MN)
  •  Letrozole Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Analysis Market by Mode Of Action (USD MN)
  •  Selective Inhibitors Market Sales by Geography (USD MN)
  •  Non-Selective Inhibitors Market Sales by Geography (USD MN)
  •  Analysis by Route Of Administration (USD MN)
  •  Oral Market Sales by Geography (USD MN)
  •  Parenteral Market Sales by Geography (USD MN)
  •  Analysis by End Users (USD MN)
  •  Hospitals Market Sales by Geography (USD MN)
  •  Homecare Market Sales by Geography (USD MN)
  •  Specialty Clinics Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Analysis by Distribution Channel (USD MN)
  •  Hospital Pharmacy Market Sales by Geography (USD MN)
  •  Online Pharmacy Market Sales by Geography (USD MN)
  •  Retail Pharmacy Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Aromatase Inhibitors Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisition
 
 LIST OF FIGURES
 
  •  Research Scope of Aromatase Inhibitors Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Aromatase Inhibitors Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Drug
  •  Market Attractiveness Analysis by Mode Of Action
  •  Market Attractiveness Analysis by Route Of Administration
  •  Market Attractiveness Analysis by End Users
  •  Market Attractiveness Analysis by Distribution Channel
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Drug (USD MN)
  •  Formestane Market Sales by Geography (USD MN)
  •  Fadrozole Market Sales by Geography (USD MN)
  •  Exemestane Market Sales by Geography (USD MN)
  •  Anastrozole Market Sales by Geography (USD MN)
  •  Letrozole Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market Analysis by Mode Of Action (USD MN)
  •  Selective Inhibitors Market Sales by Geography (USD MN)
  •  Non-Selective Inhibitors Market Sales by Geography (USD MN)
  •  Global Market Analysis by Route Of Administration (USD MN)
  •  Oral Market Sales by Geography (USD MN)
  •  Parenteral Market Sales by Geography (USD MN)
  •  Global Market Analysis by End Users (USD MN)
  •  Hospitals Market Sales by Geography (USD MN)
  •  Homecare Market Sales by Geography (USD MN)
  •  Specialty Clinics Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market Analysis by Distribution Channel (USD MN)
  •  Hospital Pharmacy Market Sales by Geography (USD MN)
  •  Online Pharmacy Market Sales by Geography (USD MN)
  •  Retail Pharmacy Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top  Company Share Analysis
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
After Sales Support
24/7 Email Support

Clients

Testimonials